Pharma-Bio Serv (OTCMKTS:PBSV) Releases Quarterly Earnings Results, Beats Expectations By $0.35 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) issued its quarterly earnings results on Monday. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.35, reports. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%. The firm had revenue of $2.47 million for the quarter, compared to the consensus estimate of $2.70 million.

Pharma-Bio Serv Stock Performance

Shares of OTCMKTS PBSV opened at $0.43 on Wednesday. The business’s 50 day moving average price is $0.55 and its 200-day moving average price is $0.57. Pharma-Bio Serv has a fifty-two week low of $0.31 and a fifty-two week high of $0.90. The company has a market cap of $9.86 million, a price-to-earnings ratio of -14.33 and a beta of 0.53.

Pharma-Bio Serv Dividend Announcement

The firm also recently declared a dividend, which will be paid on Thursday, March 20th. Stockholders of record on Friday, February 28th will be issued a $0.075 dividend. The ex-dividend date is Friday, February 28th. Pharma-Bio Serv’s payout ratio is -250.00%.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.